Langman, M J <br/><br/>
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.  [electronic resource] 

 -  JAMA  Nov 1999 
 - 1929-33 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0098-7484 
<br/><br/><label>Standard No.: </label>10.1001/jama.282.20.1929  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Analgesics, Non-Narcotic--adverse effects<br/>Anti-Inflammatory Agents, Non-Steroidal--adverse effects<br/>Butanones--adverse effects<br/>Cyclooxygenase 1<br/>Cyclooxygenase 2<br/>Cyclooxygenase 2 Inhibitors<br/>Cyclooxygenase Inhibitors--adverse effects<br/>Diclofenac--adverse effects<br/>Female<br/>Gastrointestinal Hemorrhage--chemically induced<br/>Humans<br/>Ibuprofen--adverse effects<br/>Isoenzymes<br/>Lactones--adverse effects<br/>Male<br/>Membrane Proteins<br/>Middle Aged<br/>Nabumetone<br/>Osteoarthritis--drug therapy<br/>Peptic Ulcer--chemically induced<br/>Proportional Hazards Models<br/>Prostaglandin-Endoperoxide Synthases<br/>Randomized Controlled Trials as Topic<br/>Sulfones